Of all those who have been critical of our vaccination efforts related to Covid-19, vaccine expert Geert Vanden Bossche stands out as one of the loudest voices in the crowd.
Having been featured on Dr. Chris Martenson’s Peak Prosperity and Bret Weinstein’s Dark Horse podcast, Vanden Bossche has been outspoken – yet measured and reasoned – in his critiquing of mass vaccinations during the midst of the Covid pandemic. One of his main gripes with vaccination efforts is that vaccinating during the middle of a pandemic could potentially lead to a long runway of variants, some of which may evolve to be far more difficult to deal with than the original Covid virus.
And Vanden Bossche is an expert in the space with an extensive resume. He received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He has worked for several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
He also joined the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer before working with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
He then joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office.
In a new blog post published yesterday, Vanden Bossche continued to raise questions about our mass vaccination program to fight Covid.
In a summary of his findings, he writes: “As of the early days of the mass vaccination campaigns, at least a few experts have been warning against the catastrophic impact such a program could have on global and individual health. Mass vaccination in the middle of a pandemic is prone to promoting selection and adaptation of immune escape variants that are featured by increasing infectiousness and resistance to spike protein (S)-directed antibodies (Abs), thereby diminishing protection in vaccinees and threatening the unvaccinated.”
“This already explains why the WHO’s mass vaccination program is not only unable to generate herd immunity (HI) but even leads to substantial erosion of the population’s immune protective capacity,” he continues. “As the ongoing universal mass vaccination program will soon promote dominant propagation of highly infectious, neutralization escape mutants (i.e., so-called ‘S Ab-resistant variants’), naturally acquired, or vaccinal neutralizing Abs, will, indeed, no longer offer any protection to immunized individuals whereas high infectious pressure will continue to suppress the innate immune defense system of the nonvaccinated.”
“This is to say that every further increase in vaccine coverage rates will further contribute to forcing the virus into resistance to neutralizing, S-specific Abs. Increased viral infectivity, combined with evasion from antiviral immunity, will inevitably result in an additional toll taken on human health and human lives.”
He then urges “immediate action”, writing: “Immediate action needs, therefore, to be taken in order to dramatically reduce viral infectivity rates and to prevent selected immune escape variants from rapidly spreading through the entire population, whether vaccinated or not. This first critical step can only be achieved by calling an immediate halt to the mass vaccination program and replacing it by widespread use of antiviral chemoprophylactics while dedicating massive public health resources to scaling early multidrug treatments of Covid-19 disease.”